查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球透皮给药系统市场 2023-2030
市场调查报告书
商品编码
1351034

全球透皮给药系统市场 2023-2030

Global Transdermal Drug Delivery Systems Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 130 Pages | 商品交期: 2-3个工作天内

价格

预计在预测期内（2023-2030年），全球透皮给药系统市场将以 6.5% 的复合年增长率成长。经皮给药系统（TDDS）属于受控给药系统，药物以固定且受控的速率通过皮肤输送。这些系统用于治疗各种疾病，例如心血管疾病和中枢神经系统疾病等。最近在 2023 年 4 月，FDA 更新了文件，以澄清申办者在测量 TDS 产品表面积时应考虑的适当方法。预期粘附在患者皮肤上以及如何统计分析该数据。这就是 FDA 更新通用透皮和局部给药系统指南的原因。它针对使用透皮和局部给药系统（TDS）的仿製药提交发布了两份修订指南草案。修订后的指南对简化新药申请 (ANDA) 申办者在提交上市前申请时应考虑的大量技术进行了澄清。

细分市场前景

全球透皮给药系统市场按类型和应用进行细分。根据类型，市场分为贴片和凝胶。根据应用，市场细分为高血压、晕动病、疼痛管理等。在该类型中，预计贴片细分市场将占据相当大的市场份额。由于其用于疼痛管理，这正在促进市场成长。而癌症病例的不断增加，导致疼痛补丁的加速出现。

预计疼痛管理细分市场将在全球透皮给药系统市场中占据相当大的份额

其中，疼痛管理细分市场预计将在全球透皮给药系统市场中占据相当大的份额。患者对无痛给药的偏好不断提高，导致用于给药的黏性皮肤贴片的采用率大幅上升，预计这将为该市场带来高成长潜力。因此，各公司都致力于进入并改善这一领域。例如，2023 年 6 月，Innocan Pharma Corporation 宣布向美国专利商标局 (USPTO) 提交最新专利申请。此举符合该公司扩大其独特的大麻和镁局部止痛技术组合的持续策略。

区域展望

全球透皮给药系统市场根据地理位置进一步细分，包括北美（美国和加拿大）、欧洲（英国、义大利、西班牙、德国、法国和欧洲其他地区）、亚太地区（印度、中国） 、日本、韩国和亚洲其他地区）以及世界其他地区（中东和非洲以及拉丁美洲）。其中，由于德国、英国和俄罗斯等国家拥有先进的医疗基础设施，预计欧洲将在全球市场中占有显着份额。

北美地区预计全球透皮给药系统市场复合年增长率显着成长

在所有地区中，北美地区预计在预测期内将以相当大的复合年增长率成长。区域增长归因于该地区目标疾病（如慢性疼痛、中枢神经系统疾病和心血管疾病）盛行率的上升，以及与透皮给药系统相关的研究活动数量的增加。因此，该国正大力转向采用透皮给药系统市场解决方案。例如，2023 年 4 月，DifGen Pharmaceuticals LLC 宣布收购了 Aveva Drug Delivery Services Inc.，一家完全整合的透皮给药系统 (TDS) 和口服可溶性薄膜 (ODF) 开发商和製造商。这项战略投资使我们能够扩大我们的研发和製造能力，提供复杂的剂型，并透过美国当地的製造为我们有价值的合作伙伴提供安全的供应。最重要的是，它将为患者提供负担得起的、最高品质和持续供应的救生药物」。

市场参与者展望

服务于透皮给药系统市场的主要公司包括 Boehringer Ingelheim GmbH、Echo Therapeutics Inc.、GlaxoSmithKline plc、Hisamitsu Pharmaceutical Co. Inc.、Mylan Pharmaceuticals, Inc. 等。市场参与者透过各种策略（包括併购、合作、合作、融资和新产品发布），为市场成长做出了巨大贡献，以保持市场竞争力。例如，2023年6月，Kyung Hee与Dasan Pharmaceutical签署了一项新技术转移协议，涉及一项开创性的透皮给药材料技术，该技术采用了医学院Dokyoung Kim教授开发的新型高分子化合物。

报告涵盖：

  • 2022年市场价​​值数据分析及2030年预测。
  • 每个细分市场的年化市场收入（百万美元）。
  • 主要地理区域的国家分析。
  • 全球透皮给药系统市场的主要公司。根据现有数据，报告中还提供了与新产品发布相关的资讯以及相关新闻。
  • 透过确定未来强劲成长的关键细分市场来分析业务策略。
  • 市场进入和市场扩张策略分析。
  • 透过识别市场中「谁的立场」来制定竞争策略。

目录

第 1 章：报告摘要

  • 目前行业分析及成长潜力展望
  • 研究方法和工具
  • 市场区隔
    • 按细分
    • 按地区

第 2 章：市场概述与见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
  • 3M Company
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Johnson & Johnson
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Skyepharma Production SAS
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • 关键策略分析

第 4 章：市场细分

  • 按类型分類的全球透皮给药系统市场
    • 补丁
    • 凝胶
  • 全球透皮给药系统市场（依应用）
    • 高血压
    • 晕动症
    • 疼痛管理
    • 其他（+感染、荷尔蒙、呼吸和代谢）

第 5 章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 6 章：公司简介

  • 4P Therapeutics, LLC
  • Altaris
  • Bayer AG
  • Biogel Technology, Inc.
  • Boehringer Ingelheim GmbH
  • Echo Therapeutics, Inc.
  • GlaxoSmithKline plc
  • Hisamitsu Pharmaceutical Co. Inc.
  • Mylan Pharmaceuticals, Inc.
  • Novartis AG
  • Noven Pharmaceuticals, Inc.
  • Purdue Pharma L.P.
  • Transdermal Technologies, Inc.
  • Viatris Inc.
  • Watson Pharmaceuticals, Inc.
Product Code: OMR2027635

Title: Global Transdermal Drug Delivery Systems Market Size, Share & Trends Analysis Report by Type (Patches and gel), by Application (Hypertension, Motion Sickness, Pain Management and Others),Forecast Period (2023-2030).

The global transdermal drug delivery systems market is anticipated to grow at a CAGR of 6.5% during the forecast period (2023-2030). Transdermal drug delivery system (TDDS) is the systems categorized under the controlled drug delivery, where drugs are delivered through the skin at a fixed and controlled rate. These systems are used for treating various disease conditions such as cardiovascular disorders, and central nervous system disorders, etc. Recently in April 2023, FDA updated the documents to clarify the appropriate methods sponsors should consider while measuring the surface area of the TDS product that is expected to adhere to a patient's skin and how to statistically analyze that data. That why FDA updates generic transdermal and topical delivery systems guidance's. It issued two revised draft guidance for generic drug submissions that use transdermal and topical delivery systems (TDS). The revised guidance make numerous technical clarifications that abbreviated new drug application (ANDA) sponsors should consider when filing their premarket application.

Segmental Outlook

The global transdermal drug delivery systems market is segmented on the type and application. Based on the type, the market is sub-segmented into patches and gel. Based on the application, the market is sub-segmented into hypertension, motion sickness, pain management and others. Among the type, the patches sub-segment is anticipated to hold a considerable share of the market. Owing to its use in pain management, which is boosting the market growth. And the increasing cases of cancer, lead accelerated embracing of pain patches.

The Pain Management Sub-Segment is Anticipated to Hold a Considerable Share of the Global Transdermal Drug Delivery Systems Market

Among the application, the Pain management sub-segment is expected to hold a considerable share of the global transdermal drug delivery system market. The rising patient preference for pain-free drug administration has led to a significant surge in the adoption rate of adhesive skin patches that administer drugs, which is anticipated to present the market with high growth potential. Hence Companies are focusing to enter and improve in this segment. For an instance, in June 2023, Innocan Pharma Corporation has announced the filing of its most recent patent application to the United States Patent and Trademark Office (USPTO). This move is in line with the Company's ongoing strategy to expand the breadth of its distinctive combined Cannabis and Magnesium topical pain-relief technology.

Regional Outlook

The global transdermal drug delivery systems market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Europe is anticipated to hold a prominent share of the market across the globe, owing to presence of advanced healthcare infrastructure facilities in countries like Germany, UK and Russia.

The North America Region is Expected to Grow at a Significant CAGR in the Global Transdermal Drug Delivery Systems Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the region is driven by the rising prevalence of targeted diseases (such as chronic pain, central nervous system disorders, and cardiovascular diseases) in the region, and the increasing number of research activities related to transdermal drug delivery systems. Hence, there is considerable shift of the country towards the adoption of the Transdermal Drug Delivery Systems market solutions. For an instance in April 2023, DifGen Pharmaceuticals LLC announced that it has acquired Aveva Drug Delivery Services Inc. a fully integrated developer and manufacturer of Transdermal Delivery Systems (TDS) and Oral Dissolvable Films (ODF). This strategic investment allows us to expand our R&D & manufacturing capabilities in offering complex dosage forms and secure supply to our valuable partners with local US based manufacturing. Most importantly, it will provide patients affordable lifesaving medication with highest quality and consistent supply".

Market Players Outlook

The major companies serving the transdermal drug delivery systems market includes Boehringer Ingelheim GmbH, Echo Therapeutics Inc., GlaxoSmithKline plc, Hisamitsu Pharmaceutical Co. Inc., Mylan Pharmaceuticals, Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in June 2023, Kyung Hee signed a new technology transfer agreement with Dasan Pharmaceutical for a pioneering transdermal drug delivery material technology that incorporates a novel polymer compound developed by Professor Dokyoung Kim of the College of Medicine.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global transdermal drug delivery systems market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. 3M Company
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Johnson & Johnson
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Skyepharma Production SAS
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Transdermal Drug Delivery Systems Market by Type
    • 4.1.1. Patches
    • 4.1.2. Gel
  • 4.2. Global Transdermal Drug Delivery Systems Market by Application
    • 4.2.1. Hypertension
    • 4.2.2. Motion Sickness
    • 4.2.3. Pain Management
    • 4.2.4. Others (+Infection, Hormone, Respiratory and Metabolic)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. 4P Therapeutics, LLC
  • 6.2. Altaris
  • 6.3. Bayer AG
  • 6.4. Biogel Technology, Inc.
  • 6.5. Boehringer Ingelheim GmbH
  • 6.6. Echo Therapeutics, Inc.
  • 6.7. GlaxoSmithKline plc
  • 6.8. Hisamitsu Pharmaceutical Co. Inc.
  • 6.9. Mylan Pharmaceuticals, Inc.
  • 6.10. Novartis AG
  • 6.11. Noven Pharmaceuticals, Inc.
  • 6.12. Purdue Pharma L.P.
  • 6.13. Transdermal Technologies, Inc.
  • 6.14. Viatris Inc.
  • 6.15. Watson Pharmaceuticals, Inc.

LIST OF TABLES

  • 1. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 3. GLOBAL TRANSDERMAL GEL MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 5. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS FOR HYPERTENSION MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 6. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS FOR MOTION SICKNESS MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 7. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS FOR PAIN MANAGEMENT MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 8. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS FOR OTHERS MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 9. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. NORTH AMERICAN TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 11. NORTH AMERICAN TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 12. NORTH AMERICAN TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 13. EUROPEAN TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 14. EUROPEAN TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 15. EUROPEAN TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 16. ASIA- PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 17. ASIA- PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 18. ASIA- PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 19. REST OF THE WORLD TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 20. REST OF THE WORLD TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 21. REST OF THE WORLD TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SHARE BY TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL TRANSDERMAL PATCHES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL TRANSDERMAL GEL MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 5. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS FOR HYPERTENSION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS FOR MOTION SICKNESS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS FOR PAIN MANAGEMENT MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS FOR OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. US TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 11. CANADA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 12. UK TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 13. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. GERMANY TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. ITALY TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. SPAIN TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. REST OF EUROPE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. INDIA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. CHINA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. REST OF THE WORLD TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)